Target intelligence / Profile preview

PACRG antisense RNA 2 (PACRG-AS2)

Target
PACRG-AS2
Molecular classification
Long non-coding RNA, Antisense RNA, Other
01

Overview

PACRG antisense RNA 2 (PACRG-AS2) is a long non-coding RNA (lncRNA) transcribed from the antisense strand at the PACRG locus (chromosome 6:163042980-163054161, hg38)[1][3][5]. PACRG-AS2 exhibits minimal protein-coding potential, and sequence-based computational tools consistently designate it as non-coding[1]. Its functional roles, biological pathways, disease associations, and clinical relevance are currently uncharacterized in the literature and major transcript databases[1][3][5]. No direct evidence exists to classify PACRG-AS2 as a therapeutic target, nor are there known small molecules or biologics that modulate its function. In sum, PACRG-AS2 represents a non-coding transcript with largely unknown molecular and biological functions.

Other names
ENST00000418665RP1-257A15.1-003OTTHUMT00000043009.1NONHSAT115950NR_110871NR_110871.1ENSG00000225437.1RP1-257A15.1OTTHUMG00000015973.1ENSG00000225437.5
02

Biological functions

UnknownOther
03

Disease associations

UnknownOther

Beyond the preview

Go deeper on PACRG antisense RNA 2 (PACRG-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PACRG antisense RNA 2 (PACRG-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call